BUCCAL-PEP Consortium Project

About AdhexPharma

AdhexPharma is a specialized CDMO focused on advanced drug delivery via patches and oral films, providing end-to-end services from development to manufacturing. The company has a significant production scale, a pipeline of over 15 development projects, and a history of strategic acquisitions to bolster its capabilities. It operates as a private, revenue-generating entity, serving pharmaceutical and biotech clients globally while also offering a portfolio of licensable, market-ready products.